Skip to main content
Fig. 4 | BMC Nephrology

Fig. 4

From: Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function

Fig. 4

Changes in patients’ weight (Kg) after 30 days of treatment with 10 mg Dapagliflozin daily. After being treated with Dapagliflozin, 5 patients had an increase in their weight (dark blue), 10 patients had a reduction in their weight (light blue), and 5 patients had no weight change following the treatment. Change in Weight = [Post-treatment]—[Pre-treatment]. CAPD: Continuous Ambulatory Peritoneal Dialysis

Back to article page